Efficacy Should Drive Atypical Antipsychotic Treatment

BMJ
doi 10.1136/bmj.326.7383.283/a
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Clinical Efficacy of Antipsychotic Drugs in the Treatment of Schizophrenia

Journal of Cytology & Histology
2014English

Antipsychotic Monotherapy and Polypharmacy in the Naturalistic Treatment of Schizophrenia With Atypical Antipsychotics

BMC Psychiatry
PsychiatryMental Health
2005English

Chlorpromazine Versus Atypical Antipsychotic Drugs for Schizophrenia

2013English

Atypical Antipsychotic Agents, Retinopathy, Nephropathy, and Cardiovascular Disease

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2006English

Metabolomic Mapping of Atypical Antipsychotic Effects in Schizophrenia

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2007English

Comparative Cytochrome P450In VitroInhibition by Atypical Antipsychotic Drugs

ISRN Pharmacology
2013English

Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia

Frontiers in Psychiatry
PsychiatryMental Health
2019English

Extrapyramidal Reactions From Concurrent SSRI and Atypical Antipsychotic Use

Irish Journal of Psychological Medicine
PsychiatryMental HealthPhilosophy of ScienceApplied PsychologyHistory
1998English

Bridging the Efficacy-Effectiveness Gap in the Antipsychotic Treatment of Schizophrenia: Back to the Basics

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy